Evidence map›Paper›PMID 26549759›Full record

ArticleScientific reports2015

Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli.

Yan Liu, Sylvie Mémet, Ricardo Saban, Xiangpeng Kong, Pavel Aprikian, Evgeni Sokurenko, Tung-Tien Sun, Xue-Ru Wu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Ulcerative Colitis-associatedGut microbes · 2020
    Article
  10. Innate immunity and urinary tract infection.Pediatric nephrology (Berlin, Germany) · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Yan LiuDepartment of Urology, New York University School of Medicine.
Sylvie MémetCentre d'Immunologie de Marseille-Luminy, Aix-Marseille University, UM2, Institut National de la Santé et de la Recherche Médicale (Inserm), U1104 and Centre National de la Recherche Scientifique (CNRS) UMR7280, Marseille, France.
Ricardo SabanResearch and Postgraduation of University Anhembi Morumbi, S. Paulo, SP 03164-000, Brazil.
Xiangpeng KongDepartments of Biochemistry and Molecular Pharmacology, New York University School of Medicine.
Pavel AprikianUniversity of Washington, Seattle, WA 98195.
Evgeni SokurenkoUniversity of Washington, Seattle, WA 98195.
Tung-Tien SunDepartment of Urology, New York University School of Medicine.
Xue-Ru WuDepartment of Urology, New York University School of Medicine.
New York University · USUniversity of Washington · USAnhembi Morumbi University · BRCentre d’Immunologie de Marseille-Luminy · FR

Funding

Uroplakins and Baterial InfectionP01DK052206 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SUN, TUNG-TIEN · 1999 to 2015
$19.6M
Molecular Clonality of Uropathogenic E. ColiR01AI106007 · NIAID · UNIVERSITY OF WASHINGTON · PI SOKURENKO, EVGENI VENIAMINOVIC · 2014 to 2024
$7.5M
BIOCHEMISTRY OF UROTHELIAL DIFFERENTIATIONR01DK039753 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SUN, TUNG-TIEN · 1987 to 2012
$4.6M
ROLE OF TAMM-HORSFALL PROTEIN IN URINARY TRACT DEFENSER01DK056903 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WU, XUE-RU · 2000 to 2018
$4.6M
Molecular and Genetic Studies of Bladder TumorigenesisI01BX002049 · VA · VA NEW YORK HARBOR HLTHCARE/SYS/BROOKLYN · PI WU, XUE-RU · 2014 to 2022
–
BLRD VA I01 BX002049NIAID NIH HHS R01 AI106007NIDDK NIH HHS DK52206NIDDK NIH HHS DK56903NIDDK NIH HHS P01 DK052206NIDDK NIH HHS R01 DK039753NIDDK NIH HHS R01 DK056903
6 · The paper itself

Abstract

During urinary tract infection (UTI), the second most common bacterial infection, dynamic interactions take place between uropathogenic E. coli (UPEC) and host urothelial cells. While significant strides have been made in the identification of the virulence factors of UPEC, our understanding of how the urothelial cells mobilize innate defenses against the invading UPEC remains rudimentary. Here we show that mouse urothelium responds to the adhesion of type 1-fimbriated UPEC by rapidly activating the canonical NF-κB selectively in terminally differentiated, superficial (umbrella) cells. This activation depends on a dual ligand/receptor system, one between FimH adhesin and uroplakin Ia and another between lipopolysaccharide and Toll-like receptor 4. When activated, all the nuclei (up to 11) of a multinucleated umbrella cell are affected, leading to significant amplification of proinflammatory signals. Intermediate and basal cells of the urothelium undergo NF-κB activation only if the umbrella cells are detached or if the UPEC persistently express type 1-fimbriae. Inhibition of NF-κB prevents the urothelium from clearing the intracellular bacterial communities, leading to prolonged bladder colonization by UPEC. Based on these data, we propose a model of dual ligand/receptor system in innate urothelial defenses against UPEC.

Indexed as

Adhesins, Escherichia coliAnimalsBacterial AdhesionFimbriae ProteinsGene Expression Regulation, BacterialHost-Pathogen InteractionsHumansLigandsLipopolysaccharidesMiceNF-kappa BToll-Like Receptor 4Urinary Tract InfectionsUropathogenic Escherichia coliUroplakin IaUrotheliumAdhesins, Escherichia coliFimbriae ProteinsfimH protein, E coliLigandsLipopolysaccharidesNF-kappa BToll-Like Receptor 4Uroplakin Ia

Identifiers

PMID26549759
PMCPMC4637824
OpenAlexW2414157519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.